TY  - GEN
AU  - Do,D V
AU  - Sepah,Y J
AU  - Boyer,D
AU  - Callanan,D
AU  - Gallemore,R
AU  - Bennett,M
AU  - Marcus,D M
AU  - Halperin,L
AU  - Sadiq,M A
AU  - Rajagopalan,N
AU  - Campochiaro,P A
AU  - Nguyen,Q D
TI  - Month-6 primary outcomes of the READ-3 study (Ranibizumab for Edema of the mAcula in Diabetes-Protocol 3 with high dose)
SN  - 1476-5454
PY  - 2016///0712
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Angiogenesis Inhibitors
KW  - administration & dosage
KW  - Diabetic Retinopathy
KW  - diagnosis
KW  - Double-Blind Method
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Intravitreal Injections
KW  - Macular Edema
KW  - Male
KW  - Middle Aged
KW  - Ranibizumab
KW  - Retina
KW  - pathology
KW  - Tomography, Optical Coherence
KW  - Vascular Endothelial Growth Factor A
KW  - antagonists & inhibitors
N1  - Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1038/eye.2015.142
ER  -